Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

Whether to Cancel National Trademark Registrations in Favor of a CTM Image

Whether to Cancel National Trademark Registrations in Favor of a CTM

Matthew W. Siegal & Stephen A. Fefferman

Why maintain national trademark registrations in Europe? Your biggest client, the hypothetical Copsi-Cola, Inc., a U.S. beverage manufacturer, with a 95-year-old U.S. trademark registration for the popular POWERSWEET drink, a high-sugar soda, is attempting to expand its trademark rights in the European market and needs your advice. Copsi-Cola has also owned registrations in three of the 15 European Union ("EU") member countries for more than 50 years: France, Spain and Portugal. Copsi-Cola has begun market research in advance of selling its POWERSWEET drink in five more EU member countries, including the United Kingdom, Germany and the Benelux countries, and has asked you to file applications in the national trademark offices in those countries. Copsi-Cola also wants the option of using its mark in all EU member countries.

Features

Study: Forget the 'Blockbusters' Image

Study: Forget the 'Blockbusters'

ALM Staff & Law Journal Newsletters

A study whose results were reported December 8 asserts that the pharmaceutical industry's "blockbuster" approach to developing new drugs is no longer viable in today's marketplace.

Canadian Pharmaceutical Agency Wants Ban on Exports to U.S. Image

Canadian Pharmaceutical Agency Wants Ban on Exports to U.S.

ALM Staff & Law Journal Newsletters

The Canadian National Association of Pharmacy Regulatory Authorities (NAPRA), Canada's voluntary umbrella association of provincial and territorial pharmacy licensing bodies, has asked the Canadian government to legislate against the export of drug products to the United States.

OK to Use 'Research Tool' Patents Offshore? Image

OK to Use 'Research Tool' Patents Offshore?

Harold Wegner & Stephen Maebius

The U.S. Court of Appeals for the Federal Circuit has confirmed that there is no patent infringement liability under 35 U.S.C. 271(g)(1) for the offshore use of a "research tool" patent when only the information gained from such offshore use is introduced into the United States.

Case Briefing Image

Case Briefing

ALM Staff & Law Journal Newsletters

Recent rulings of importance to you and your practice.

Features

News from the FDA Image

News from the FDA

ALM Staff & Law Journal Newsletters

The latest news you need to know.

Features

Patent Protection or <i>Per Se</i> Antitrust Violation? Image

Patent Protection or <i>Per Se</i> Antitrust Violation?

Neal R. Stoll & Shepard Goldfein

As the winter months approached, a storm was brewing in the antitrust world. The U.S. Courts of Appeals for the Sixth and Eleventh circuits have split over the per se illegality of Hatch-Waxman patent-settlement agreements by which a patent-holding drug maker pays a generic drug company to delay its entry into the market. The Federal Trade Commission (FTC) has harshly criticized these agreements, and now the Supreme Court has an opportunity to calm the fury.

Features

Landlord & Tenant Image

Landlord & Tenant

ALM Staff & Law Journal Newsletters

Recent rulings of importance to your practice.

Development Image

Development

ALM Staff & Law Journal Newsletters

Recent rulings of importance to your practice.

Features

Real Property Law Image

Real Property Law

ALM Staff & Law Journal Newsletters

Recent rulings of interest to your practice.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES